comparemela.com

Latest Breaking News On - எடுப்போசை சுவாச - Page 5 : comparemela.com

RB Capital Increases Investment in Sunshine Biopharma

Published: Apr 22, 2021 MONTREAL, April 22, 2021 (GLOBE NEWSWIRE) Sunshine Biopharma, Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that RB Capital has injected an additional investment of $500,000 to augment the Company’s Coronavirus drug development program. In addition, RB Capital has provided the Company with assurances that it will continue to provide funding over the next 30 days for the Company’s other R&D activities, including Ada-27a anticancer drug. Sunshine Biopharma’s CFO, Camille Sebaaly stated, “We are very pleased to continue our relationship with RB Capital as long-term investor in the Company. They truly understand our vision and are prepared to help us reach our exciting drug development objectives.”

The Need for Comprehensive Diagnostics Remains as Cases Spike Once More

The Need for Comprehensive Diagnostics Remains as Cases Spike Once More FinancialBuzz.com News Commentary Share this article Share this article NEW YORK, April 20, 2021 /PRNewswire/  The Director of the U.S. National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci, and many other experts have warned that rapid reopening and lifting of pandemic restrictions in many states, as well as the proliferation of more contagious variants, will likely result in ongoing and increased spread of the virus in hot spots around the country. The pandemic remains a very real threat as the number of new cases spiked in the United States once again. Dr. Abdul El-Sayed, a former health commissioner for Detroit, explained, according to a report by CNN, that vaccines don t work until they hit people s arms - and we just don t have enough vaccinations in people s arms yet to be able to achieve the kind of herd immunity that we need. Sunshine Biopharma Inc. (OTC: SBFM), Fluidigm Corpor

Sunshine Biopharma Reports Favorable MTD Results for COVID-19 Treatment

Published: Apr 19, 2021 MONTREAL, April 19, 2021 (GLOBE NEWSWIRE) Sunshine Biopharma, Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has successfully completed a Maximum Tolerated Dose (MTD) study in mice. Sunshine Biopharma is pleased to report that the MTD results are favorable and fall within the optimum range for use in humans. Next, Sunshine Biopharma will use the test dose indicated by these results to conduct the efficacy studies in hACE2-transgenic mice. Sunshine Biopharma’s COVID-19 treatment is an inhibitor of PLpro, a protease present only in the SARS Coronaviruses (Betacoronaviruses) and is an important antiviral target as it is involved in shutting down the host innate immune system thereby causing significantly greater morbidity.

Corona in Braunschweig: Fakten, Krankheitssymptome, Virus

Corona in Braunschweig: Fakten, Krankheitssymptome, Virus
braunschweiger-zeitung.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from braunschweiger-zeitung.de Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.